002589 Stock Overview
Sells medicines, medical devices, and medical consumables to medical institution worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Realcan Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.98 |
| 52 Week High | CN¥3.67 |
| 52 Week Low | CN¥2.07 |
| Beta | 0.49 |
| 1 Month Change | 5.67% |
| 3 Month Change | -10.24% |
| 1 Year Change | 19.68% |
| 3 Year Change | -23.00% |
| 5 Year Change | -55.19% |
| Change since IPO | 12.18% |
Recent News & Updates
We Think Realcan Pharmaceutical Group (SZSE:002589) Has A Fair Chunk Of Debt
Dec 12
Realcan Pharmaceutical Group (SZSE:002589) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 06Improved Revenues Required Before Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Stock's 36% Jump Looks Justified
Oct 18Recent updates
We Think Realcan Pharmaceutical Group (SZSE:002589) Has A Fair Chunk Of Debt
Dec 12Realcan Pharmaceutical Group (SZSE:002589) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 06Improved Revenues Required Before Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Stock's 36% Jump Looks Justified
Oct 18Realcan Pharmaceutical Group's (SZSE:002589) Earnings Seem To Be Promising
May 06Shareholder Returns
| 002589 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 1.4% | 1.8% | -0.08% |
| 1Y | 19.7% | -4.1% | 17.3% |
Return vs Industry: 002589 exceeded the CN Healthcare industry which returned -4.1% over the past year.
Return vs Market: 002589 exceeded the CN Market which returned 17.3% over the past year.
Price Volatility
| 002589 volatility | |
|---|---|
| 002589 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 002589 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002589's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 3,239 | Xu Han | www.realcan.cn |
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. The company operates in Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine segments. It sells drugs and medical devices.
Realcan Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 002589 fundamental statistics | |
|---|---|
| Market cap | CN¥4.44b |
| Earnings (TTM) | CN¥39.90m |
| Revenue (TTM) | CN¥7.99b |
111.8x
P/E Ratio0.6x
P/S RatioIs 002589 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002589 income statement (TTM) | |
|---|---|
| Revenue | CN¥7.99b |
| Cost of Revenue | CN¥7.19b |
| Gross Profit | CN¥794.29m |
| Other Expenses | CN¥754.39m |
| Earnings | CN¥39.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 24, 2025
| Earnings per share (EPS) | 0.027 |
| Gross Margin | 9.95% |
| Net Profit Margin | 0.50% |
| Debt/Equity Ratio | 123.8% |
How did 002589 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield76%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/19 16:00 |
| End of Day Share Price | 2025/02/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Realcan Pharmaceutical Group Co., Ltd. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yalei Yan | Bohai Securities Co., Ltd. |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Xu Qing Liu | Chasing Securities |